iRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est
iRadimed (NASDAQ:IRMD) affirms FY2026 GAAP EPS guidance from $1.90-$2.05 to $1.90-$2.05 vs $1.91 analyst estimate..
iRadimed stuck with its earlier promise that each share of the company will earn between $1.90 and $2.05 in 2026, which is very close to what experts predicted. When a company keeps the same promise instead of raising or lowering it, watch whether people still trust the company to hit that target.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.